Publications

Zink A, Zenke S, Wiese T, Beyersdorf N, Lämmermann T, Rohr JC. 2023. Analyzing trogocytosis of T lymphocytes by flow cytometry and confocal microscopy. STAR Protoc. Jan 11;4(1):102013. doi: 10.1016/j.xpro.2022.102013.

Maccari ME, Schneider P, Smulski CR, Meinhardt A, Pinto F, Gonzalez-Granado LI, Schuetz C, Sica MP, Gross M, Fuchs I, Kury P, Heeg M, Vocat T, Willen L, Thomas C, Hühn R, Magerus A, Lorenz M, Schwarz K, Rieux-Laucat F, Ehl S, Rensing-Ehl A. Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations. J Allergy Clin Immunol. 2023 Jan 5:S0091-6749(23)00001-5. doi: 10.1016/j.jaci.2022.11.028.

van Otterdijk, S. D., H. Klett, M. Boerries, and K. B. Michels. 2023. The impact of pre-pregnancy folic acid intake on placental DNA methylation in a fortified cohort. FASEB J 37: e22698. doi: 10.1096/fj.202200476RR.

Rapp, J., M. Jung, R. F. U. Klar, J. Wolf, J. Arnold, O. Gorka, O. Gross, C. Lange, H. Agostini, G. Schlunck, and F. Bucher. 2022. STAT3 signaling induced by IL-6 family cytokines modulates angiogenesis. J Cell Sci. :jcs.260182. doi: 10.1242/jcs.260182.

Ruckert, T., G. Andrieux, M. Boerries, K. Hanke-Muller, N. M. Woessner, S. Doetsch, C. Schell, K. Aumann, J. Kolter, A. Schmitt-Graeff, M. Schiff, L. M. Braun, E. Haring, S. Kissel, B. A. Siranosian, A. S. Bhatt, P. Nordkild, J. Wehkamp, B. A. H. Jensen, S. Minguet, J. Duyster, R. Zeiser, and N. Kohler. 2022. Human beta-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling. Sci Transl Med 14: eabp9675. doi: 10.1126/scitranslmed.abp9675.

Rush-Kittle, J., L. Gamez-Diaz, and B. Grimbacher. 2022. Inborn errors of immunity associated with defects of self-tolerance checkpoints: The CD28 family. Pediatr Allergy Immunol 33: e13886. doi: 10.1111/pai.13886.

Weissert, K., S. Ammann, T. Kogl, V. Dettmer-Monaco, C.  Schell, T. Cathomen, S. Ehl, and P. Aichele. 2022. Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH). EMBO Mol Med: e16085. doi: 10.15252/emmm.202216085.

Jacobsen, E. M., D. Fabricius, M. Class, F. Topfstedt, R. Lorenzetti, I. Janowska, F. Schmidt, J. Staniek, M. Zernickel, T. Stamminger, A. N. Dietz, A. Zellmer, M. Hecht, P. Rauch, C. Blum, C. Ludwig, B. Jahrsdorfer, H. Schrezenmeier, M. Heeg, B. Mayer, A. Seidel, R. Gross, J. Munch, F. Kirchhoff, S. F. N. Bode, G. Strauss, H. Renk, R. Elling, M. Stich, R.E. Voll, B. Tonshof, A. R. Franz, P. Henneke, K. M. Debatin, M. Rizzi, and A. Janda. 2022. High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection. Nat Commun 13: 7315. doi: 10.1038/s41467-022-35055-1.

Corrales, E., E. Levit-Zerdoun, P. Metzger, R. Mertes, A. Lehmann, J. Munch, S. Lemke, S. Kowar, and M. Boerries. 2022. PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma. Cell Commun Signal 20: 187. doi: 10.1186/s12964-022-00989-y.

Kraemer, A. N., A. L. Schafer, D. T. L. Sprenger, B. Sehnert, J. P. Williams, A. Luo, L. Riechert, Q. Al-Kayyal, H. Dumortier, J. D. Fauny, Z. Winter, K. Heim, M. Hofmann, M. Herrmann, G. Heine, R. E. Voll, and N. Chevalier. 2022. Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice. Front Immunol 13: 933191. doi: 10.3389/fimmu.2022.933191.

Ferrarese, R., A. Izzo, G. Andrieux, S. Lagies, J. P. Bartmuss, A. P. Masilamani, A. Wasilenko, D. Osti, S. Faletti, R. Schulzki, S. Yuan, E. Kling, V. Ribecco, D. H. Heiland, S. Tholen, Prinz, G. Pelicci, B. Kammerer, M. Boerries, and M. S. Carro. 2023. ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. Life Sci Alliance 6: e202201400. doi: 10.26508/lsa.202201400.

Locatelli, G., F. Marques-Ferreira, A. Katsoulas, V. Kalaitzaki, M. Krueger, B. Ingold-Heppner, S. Walthert, R. Sankowski, O. Prazeres da Costa, A. Dolga, M. Huber, M. Gold, C. Culmsee, A. Waisman, I. Bechmann, V. Milchevskaya, M. Prinz, A. Tresch, B. Becher, and T. Buch. 2022. IGF1R expression by adult oligodendrocytes is not required in the steady-state but supports neuroinflammation. Glia. doi: 10.1002/glia.24299. doi: 10.1002/glia.24299.

Carvalho LAR, Ross B, Fehr L, Bolgi O, Wöhrle S, Lum KM, Podlesainski D, Vieira AC, Kiefersauer R, Félix R, Rodrigues T, Lucas SD, Groß O, Geiss-Friedlander R, Cravatt BF, Huber R, Kaiser M, Moreira R. 2022. Chemoproteomics-Enabled Identification of 4-Oxo-β-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9. Angew Chem Int Ed Engl. 61(47):e202210498. doi: 10.1002/anie.202210498.

Krausz, M., N. Mitsuiki, V. Falcone, J. Komp, S. Posadas-Cantera, H. M. Lorenz, J. Litzman, D. Wolff, M. Kanariou, A. Heinkele, C. Speckmann, G. Hacker, H. Hengel, L. Gamez-Diaz, and B. Grimbacher. 2022. Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency? Front Immunol 13: 1011646. doi: 10.3389/fimmu.2022.1011646.

Globig, A. M., V. Strohmeier, R. Surabattula, D. J. Leeming, M. A. Karsdal, M. Heeg, G. Kindle, S. Goldacker, C. von Spee-Mayer, M. Proietti, B. Bausch, D. Bettinger, M. Schultheiss, R. Thimme, D. Schuppan, and K. Warnatz. 2022. Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency. J Clin Immunol. pii: 10.1007/s10875-022-01319-0. doi: 10.1007/s10875-022-01319-0.

Gruninger, P. K., F. Uhl, H. Herzog, G. Gentile, M. Andrade-Martinez, T. Schmidt, K. Han, D. W. Morgens, M. C. Bassik, M. L. Cleary, O. Gorka, R. Zeiser, O. Gross, and J. Duque-Afonso. 2022. Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia. Cancer Gene Ther. pii: 10.1038/s41417-022-00491-0. doi: 10.1038/s41417-022-00491-0.